Bolt Biotherapeutics, Inc. (BOLT) NASDAQ
5.11
-0.2(-3.77%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
5.11
-0.2(-3.77%)
Currency In USD
| Market Cap | 10.23M |
| Enterprise Value | 21.48M |
| P/E Ratio | -0.32 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 1.51 |
| Price/Book Ratio | 0.48 |
| Enterprise/Revenue | 3.16 |
| Enterprise/EBITDA | -0.71 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -4.55 |
| Operating Margin | -4.63 |
| Return On Assets | -0.62 |
| Return On Equity | -1.01 |
| Revenue | 7.7M |
| Revenue/Share | 3.48 |
| Gross Profit | 6.2M |
| EBITDA | -33.14M |
| Net Income | -33.38M |
| Diluted EPS | -17.85 |
| Total Cash | 22.89M |
| Total Cash/Share | 12.24 |
| Total Debt | 22.31M |
| Total Debt/Equity | 1.13 |
| Current Ratio | 3.51 |
| Book Value Per Share | 10.6 |
| 52-Week Change | -16.37 |
| 52-Week High | 7.35 |
| 52-Week Low | 3.91 |
| Moving Average 50 Days | 4.76 |
| Moving Average 200 Days | 5.18 |
| Average Volume | 24,379 |
| Shares Outstanding | 1.92M |
| % Held by Institutions | 32.8 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | June 09, 2025 |